Cathie Wood’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $167M | Sell |
32,988,631
-1,826,871
|
|
||||
|
2025
Q1 | $184M | Buy |
34,815,502
+2,469,104
|
|
||||
|
2024
Q4 | $219M | Sell |
32,346,398
-422,788
|
|
||||
|
2024
Q3 | $216M | Buy |
32,769,186
+4,626,268
|
|
||||
|
2024
Q2 | $211M | Buy |
28,142,918
+3,555,357
|
|
||||
|
2024
Q1 | $245M | Buy |
24,587,561
+3,933,274
|
|
||||
|
2023
Q4 | $204M | Buy |
20,654,287
+13,777,689
|
|
||||
|
2023
Q3 | $52.6M | Buy |
6,876,598
+2,138,081
|
|
||||
|
2023
Q2 | $35.4M | Buy |
4,738,517
+1,161,655
|
|
||||
|
2023
Q1 | $23.9M | Buy |
3,576,862
+477,372
|
|
||||
|
2022
Q4 | $23.9M | Sell |
3,099,490
-260,321
|
|
||||
|
2022
Q3 | $35.7M | Buy |
3,359,811
+627,724
|
|
||||
|
2022
Q2 | $16.7M | Sell |
2,732,087
-95,076
|
|
||||
|
2022
Q1 | $20.2M | Buy |
2,827,163
+595,150
|
|
||||
|
2021
Q4 | $38.2M | Sell |
2,232,013
-361,823
|
|
||||
|
2021
Q3 | $59.7M | Buy |
2,593,836
+215,161
|
|
||||
|
2021
Q2 | $86.8M | Buy |
+2,378,675
|
|